HEALTHVTDIGGER
Cutting GLP-1 coverage may cost UVM Health more than it saves
UVM Health is considering eliminating GLP-1 medication coverage for weight management to save $19 million annually. The author argues this decision overlooks long-term healthcare cost savings from improved patient outcomes, such as reduced specialist visits and chronic disease risks.
Mentioned
Related Signal
Adjacent reporting
- UVM Health to suspend weight loss drug coverage for its employees
- Can California afford to cover Ozempic for public employees?
- STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and more
- This CEO wants to cover weight loss drugs for employees. They're just too expensive.
- US states drop Medicaid coverage of GLP-1 weight-loss drugs as demand rises
- STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more